Using stringent criteria, we followed-up a genome-wide association study (GWAS) finding 1 to examine the involvement of the developmental regulatory gene NOTCH4 in schizophrenia. This is the first study in a Japanese population that satisfies genomewide significance between a particular single-nucleotide polymorphism (SNP) and schizophrenia.
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population Using stringent criteria, we followed-up a genome-wide association study (GWAS) finding 1 to examine the involvement of the developmental regulatory gene NOTCH4 in schizophrenia. This is the first study in a Japanese population that satisfies genomewide significance between a particular single-nucleotide polymorphism (SNP) and schizophrenia.
The past 5 years have seen significant genetic discoveries made through GWASs. Although in schizophrenia the effect sizes have been relatively small (odds ratio (OR) of o1.2), these studies a b c d Figure 1 . Paternal-age associated DNA Methylation differences across differentially methylated regions (DMRs) associated with brain-expressed imprinted genes analysed using Sequenom EpiTyper. Offspring of young fathers n ¼ 18, offspring of old fathers n ¼ 23, *Po0.05, þ Po0.1, bars denote ± s.e.m. (a) Average DNA methylation across all DMRs analysed. Consistent paternal --age-associated DNA methylation differences were observed in CpG sites in DMRs associated with the regulation of (b) Nesp, (c) Kcnq1ot1 and (d) Mcts2.
collectively provide strong evidence for association of a number of susceptibility genes. The major loci identified for schizophrenia risk are located in the major histocompatibility complex region in 6p21.3--p22.1. The Psychiatric GWAS Consortium, a sample consisting mainly of Caucasian subjects, reported 136 SNPs with genome-wide significance (5 Â 10 À8 ), and among them 129 SNPs were located from 25 to 33 Mb at chromosome 6.
2 In addition, a recent Asian GWAS from a Chinese population showed a stringent level of significance at ZKSCAN4 (chr6: 28.32 Mb), 3 even though another larger Chinese population GWAS 4 and our prior Japanese population-based GWAS (total sample size: 1108) 1 did not detect any genome-wide significance in this region. In our previous study, 1 however, only one signal within these loci maximized at a SNP (rs2071287: chr6: 32 170 433 bp on hg19) in NOTCH4 (chr6: 32.16 to 32.19 Mb). To provide a more complete analysis, in the current study, we expanded the sample size to verify whether this SNP (rs2071287: C4T) in NOTCH4 shows strong support for genetic association.
Six case--control data sets from Japanese population, including our screening GWAS (JPN_GWAS), replication set (Rep_JPN) and the sample of Tochigi et al., 1 were evaluated. The other three new data sets consist of REP1, REP2 and REP3, the sample sets being divided by the collection regions in Japan: REP1 (Mid-east Japan: case ¼ 3173, control ¼ 3540), REP2 (Mid-west Japan: case ¼ 672, control ¼ 5321), and REP3 (South island of Japan (Shikoku): case ¼ 569, control ¼ 1622) (Supplementary Method). The TaqMan assay (Applied Biosystems, Foster City, CA, USA) was used to determine the genotypic distribution of rs2071287. A metaanalysis was performed with a fixed model by 'rmeta', an R package, as we did not apply a principal component analysis, which is the most common approach to adjust the population structure. Instead, we conducted a stratified analysis according to the sample collection site in order to rule out possible population stratification. A test for heterogeneity did not show significant deviation for combined replication data sets (REP1--REP3,
) and all data sets, including samples from our prior study (w 2 ¼ 4.2, df ¼ 5, P ¼ 0.52). Previously, we reported an association based upon three data sets with P meta at 5.1 Â 10 À5 and OR of 0.83 (reference: T allele: minor allele, 95% confidence intervals: CIs: 0.77--0.91: 'Summary1' in Figure 1) . 1 In the current study, in two out of three replication sets, we detected statistical evidence (Po0.05, two-tailed) for a consistent association that was similar in magnitude and direction (T allele in control is more frequent than in case: Figure 1 ). Further meta-analysis of the combined samples for the new data sets (REP1--REP3: case ¼ 4414, control ¼ 10 483) suggests strong support for the association of this SNP (P ¼ 7.9 Â 10 À5 : OR ¼ 0.89, 95% CI ¼ 0.84--0.94, 'Summary2' in Figure 1 ). Finally, genome-wide significance was detected in the meta-analysis combining all of the data sets (6668 case and 12 791 controls) in the Japanese population (P ¼ 3.4 Â 10 À8 : OR ¼ 0.87, 95% CI ¼ 0.83--0.92, 'ALL combined' in Figure 1 ).
Our results provide stringent support for previous genetic findings reporting the association of an intronic SNP (rs3131296, chr6: 32 172 993 bp on hg19) in NOTCH4 in a European cohort. 5 However, the pattern of linkage disequilibrium (LD) between the current (rs2071287) and previous (rs3131296) SNPs, in addition to the minor allele frequencies (MAFs) of these SNPs vary across populations ( Supplementary Figures 1 and 2) : (1) (2) rs3131296, the SGENE-plus study 5 reported significant association, shows substantially higher MAF in Caucasian (8.5% in HapMap CEU, 13% in SGENE-plus) than in Japanese (1.9% in HapMap JPT). Considering that the major histocompatibility complex region consists of large blocks with a very high LD, 6 it would be difficult to ascribe the difference to particular SNP(s). Nevertheless, given the evidence for the association of NOTCH4 with schizophrenia based upon current and previous genetic and biological support, 7 we suggest that NOTCH4 remains one of the strongest candidate susceptibility genes for schizophrenia, and we propose this SNP is a key to the identification of causal variant(s). Schizophrenia is a complex psychiatric disorder with a high heritability. The exact mechanism and risk factors for this disease have not been sufficiently resolved despite decades of extensive study. 1 Recently, two genome-wide association studies (GWAS) in Han Chinese identified a total of nine single-nucleotide polymorphisms (SNPs) that reached genome-wide significance level, 2, 3 but none of these risk loci was overlapped in the two studies. We genotyped these SNPs in Han Chinese from Hunan Province, China, and identified no association of any claimed SNP with schizophrenia.
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A total of 976 unrelated schizophrenia patients and 1,043 matched healthy controls, all of Han Chinese, were recruited from Hunan Province in Central China. Patients with schizophrenia were diagnosed independently by two psychiatrists according to DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) criteria. The controls were clinically diagnosed as having no psychiatric disorders or other diseases. All participants or supervisors of patients signed informed consent and this study was approved by the institutional review boards of the Kunming Institute of Zoology and the Second Xiangya Hospital.
The nine SNPs were genotyped by using SNaPshot (Supplementary Table S1 and Supplementary Figure S1) . No deviation from Hardy--Weinberg equilibrium was observed for each SNP in either cases or controls ( Table 1 ). The SNaPshot results were fully validated in 1% of genotyped individuals who were randomly selected for sequencing. There was no significant difference for allele frequency of the nine SNPs in case--control samples (Table 1) .
Genotype and haplotype associations were conducted by using PLINK. 4 None of the nine SNPs showed a positive association with schizophrenia (P40.05; Table 1 Figure S2 and Supplementary Table S4) , suggesting remarkable ethnic differences.
The lack of validation for any risk SNPs identified in the two GWAS of Han Chinese with schizophrenia 2,3 in our samples was not unexpected, considering the fact that none of the susceptible loci was overlapped in both studies. There are several explanations that would account for the failure to validate the GWAS results.
2,3 First, our sample was not as large as the ones used in both GWAS studies. 2, 3 However, the G* power analysis showed that our sample had sufficient power to detect the potential association between SNPs and schizophrenia (Supplementary Materials and methods). Second, confounding factors such as population stratification might have caused an undetected bias and led to a false result. Moreover, single studies (even if based on large sample size) might have limited power to detect small gene effects in complex diseases such as schizophrenia. 5 We found no apparent population stratification between our case and control populations based on the principal component analysis of the matrilineal genetic component of our sample and reported Han Chinese populations across China (authors' unpublished data). Comparison of minor allele frequencies of the nine SNPs between our sample and the GWAS cohorts 2, 3 further demonstrated regional difference: significant differences were observed for rs1233710 between our controls and the controls in Yue et al.'s study 3 and for rs2142731 between our case or control samples and the controls in Yue et al.'s study 3 (Supplementary  Table S5 ). It can be tentatively said that regional differences accounted for the failure of independent validation. Our results supported the notion of high genetic heterogeneity of schizophrenia. 1 Excessive number of variants with smaller effect, structural variations, somatic mutations, gene--gene interactions and the effect of environmental factors may also have a crucial role in schizophrenia and account for the missing heritability. 6 There are several limitations in the present study. First, we lacked detailed clinical information for each participant among our patients and reported GWAS cohorts, which prevented us from performing further association analysis between specific psychiatric phenotypes and SNP. Aggregating all patients with different subtypes together as a schizophrenia population may camouflage a real association of SNP with subtype. Second, we did not perform a fine-grained analysis for those regions that contained reported susceptible SNPs with a higher density of
